Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;3(5):206-7.

Challenges of incorporating pharmacogenomics into clinical practice

Affiliations

Challenges of incorporating pharmacogenomics into clinical practice

Sharon Marsh et al. Gastrointest Cancer Res. 2009 Sep.
No abstract available

PubMed Disclaimer

Similar articles

Cited by

  • Irinotecan pharmacogenomics.
    Marsh S, Hoskins JM. Marsh S, et al. Pharmacogenomics. 2010 Jul;11(7):1003-10. doi: 10.2217/pgs.10.95. Pharmacogenomics. 2010. PMID: 20602618 Free PMC article. Review.

References

    1. Yalçin Ş. The increasing role of pharmacogenetics in the treatment of gastrointestinal cancers. Gastrointest Cancer Res. 2009;3:197–203. - PMC - PubMed
    1. Evans WE, McLeod HL. Pharmacogenomics—drug disposition, drug targets, and side effects. N Engl J Med. 2003;348:538–549. - PubMed
    1. Flockhart D, Skaar T, Berlin D, et al. Clinically available pharmacogenomics tests. Clin Pharmacol Ther. 2009;86:109–113. - PMC - PubMed
    1. McLeod HL, King CR, Marsh S. Application of pharmacogenomics in the individualization of chemotherapy for gastrointestinal malignancies. Clin Colorectal Cancer. 2004;4(suppl 1):S43–S47. - PubMed
    1. Marsh S. Pharmacogenetics of colorectal cancer. Expert Opin Pharmacother. 2005;6:2607–2616. - PubMed

LinkOut - more resources